SRCLD 2022 Online Submission Form
Note: Do not use the ENTER key for moving from one field/box to another. Please use the TAB key or the mouse pointer instead.
Contact Person
First Name: Last Name:
Affiliation:
Department:
Include affiliation and department in mailing address?
Street Address:
City: State/Province:
Zip/Postal Code: Country:
Phone:
EMail:

Submission
Submitted Oral Presentation
Your submission will automatically be considered for a poster presentation. If you would additionally like your submission to be considered for a Submitted Oral Presentation, specify here.

Title/Author(s)
Title (max 255 characters - as you would like it to show in the conference program):

  

Author(s) (list a maximum of 10):

Please enter all affiliations for an author in the single box that corresponds to the author's name. In the box, list the primary affiliation first (i.e, 'University of Wisconsin-Madison, Penn State University').

IMPORTANT: If you are creating this submission AND you are one of the authors, you must re-enter your name and affiliation(s) in this section.

  Author First Name Author Last Name Affiliation(s)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Presenter's Race/Ethnicity
The NIH requires that we collect this information. Please specify the racial and ethnic category that best describes the presenter (if multiple presenters, choose one):

Abstract
Please enter your abstract (Max 180 words). Either type it in or copy it from your document and paste it in the space below. Please cite funding source(s) as the last line of your abstract:

Summary File
Max 600 words (charts, figures, tables, graphs, etc. are not included in the word limit):

Please upload your summary document, it should be one of the following formats: MS Word (.doc), Rich Text Format (.rtf), Portable Document Format (.pdf) or a text file (.txt)
  • Be sure a title is included at the top of the summary
  • Do not include author names or affiliations in the summary
Click this button to select your Summary file from your computer:
Comments
Please enter any comments you may have pertaining to your submission: